ANHL12P1 A Randomized Phase II Trial of Brentuximab Vedotin (SGN35, NSC# 749710) or Crizotinib (NSC# 749005, commercially labeled) in Combination with Chemotherapy for Newly Diagnosed Patients with Anaplastic Large Cell Lymphoma (ALCL) IND#117117
This Study is
No Longer Enrolling
Details
Age
Child
Type of Study
Treatment
Scope
National
Locations
Childrens Hospital Colorado
Study ID
Protocol Number: 15-1921
More information available at ClinicalTrials.gov: NCT01979536
Categories
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers